NOVEL STRATEGIES TO ENHANCE LPL ACTIVITY IN VIVO

Lipoprotein lipase (LPL) is required for the clearance of triglycerides (TG) from the bloodstream. LPL is anchored to the walls of blood vessels where it undergoes conformational changes to engage TG-rich lipoprotein particles, hydrolyze TG within the particle, and release free fatty acids. LPL activity is tightly regulated in a nutrient-dependent manner to coordinate the delivery of free fatty acids to specific tissues. The unique ability of LPL to directly control plasma TG levels makes it a good target for specific TG-lowering therapeutics. However, directly targeting LPL may be a difficult as it has several regulatory partners and disruption of activators or its endothelial anchor will abolish LPL activity. Alternatively, pharmacologic modulation of proteins that regulate LPL has been shown to dramatically lower plasma TG levels in both preclinical animal models and human clinical trials. One approach is to inactivate a subset of LPL inhibitory proteins, known as angiopoietin-like protein 3 or 4 (ANGPTL3, 4). Despite not knowing the molecular mechanism for how ANGPTL3 inhibits LPL, anti-ANGPTL3 monoclonal antibodies have shown great promise in clinical trials for severe HTG. The molecular mechanism for ANGPTL4-mediated inhibition of LPL has been more thoroughly investigated; however, therapeutic strategies that result in complete loss of ANGPTL4 have not been successful in preclinical animal models. This thesis aims to better understand the molecular mechanism of LPL inhibition by ANGPTL3 and ANGPTL4 and use this information to enhance the activity of LPL in vivo. To better understand the molecular mechanisms of ANGPTL-mediated inhibition of LPL, we i) performed biophysical experiments to compare ANGPTL3 and ANGPTL4 in vitro, ii) looked for differences in LPL inhibition and iii) identified ANGPTL4 binding sites on LPL. Lastly, we sought to improve upon existing ANGPTL4 inhibitors by generating a domain-specific inhibitor of ANGPTL4 to prevent LPL inhibition. Overall, we have identified LPL variants with ANGPTL4 resistance and an anti-ANGPTL4 single domain antibody for inactivation of the N-terminal domain of ANGPTL4. These results could have implications for future biologic-based therapeutics for hypertriglyceridemia and acute pancreatitis.Doctor of Philosoph

Mapping the sites of the lipoprotein lipase (LPL)–angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition

Cardiovascular disease has been the leading cause of death throughout the world for nearly 2 decades. Hypertriglyceridemia affects more than one-third of the population in the United States and is an independent risk factor for cardiovascular disease. Despite the frequency of hypertriglyceridemia, treatment options are primarily limited to diet and exercise. Lipoprotein lipase (LPL) is an enzyme responsible for clearing triglycerides from circulation, and its activity alone can directly control plasma triglyceride concentrations. Therefore, LPL is a good target for triglyceride-lowering therapeutics. One approach for treating hypertriglyceridemia may be to increase the amount of enzymatically active LPL by preventing its inhibition by angiopoietin-like protein 4 (ANGPTL4). However, little is known about how these two proteins interact. Therefore, we used hydrogen– deuterium exchange MS to identify potential binding sites between LPL and ANGPTL4. We validated sites predicted to be located at the protein–protein interface by using chimeric variants of LPL and an LPL peptide mimetic. We found that ANGPTL4 binds LPL near the active site at the lid domain and a nearby -helix. Lipase lid domains cover the active site to control both enzyme activation and substrate specificity. Our findings suggest that ANGPTL4 specifically inhibits LPL by binding the lid domain, which could prevent substrate catalysis at the active site. The structural details of the LPL–ANGPTL4 interaction uncovered here may inform the development of therapeutics targeted to disrupt this interaction for the management of hypertriglyceridemia

High-speed domain wall racetracks in a magnetic insulator

Recent reports of current-induced switching of ferrimagnetic oxides coupled to a heavy metal layer have opened realistic prospects for implementing magnetic insulators into electrically addressable spintronic devices. However, key aspects such as the configuration and dynamics of magnetic domain walls driven by electrical currents in insulating oxides remain unexplored. Here, we investigate the internal structure of the domain walls in Tm3Fe5O12 (TmIG) and TmIG/Pt bilayers and demonstrate their efficient manipulation by spin-orbit torques with velocities of up to 400 m s$^{-1}$ and minimal current threshold for domain wall flow of 5 x 10$^{6}$ A cm$^{-2}$. Domain wall racetracks embedded in TmIG are defined by the deposition of Pt current lines, which allow us to control the domain propagation and magnetization switching in selected regions of an extended magnetic layer. Scanning nitrogen-vacancy magnetometry reveals that the domain walls of thin TmIG films are N\'eel walls with left-handed chirality, with the domain wall magnetization rotating towards an intermediate N\'eel-Bloch configuration upon deposition of Pt. These results indicate the presence of a sizable interfacial Dzyaloshinskii-Moriya interaction in TmIG, which leads to novel possibilities to control the formation of chiral spin textures in magnetic insulators. Ultimately, domain wall racetracks provide an efficient scheme to pattern the magnetic landscape of TmIG in a fast and reversible wa

Identification of Fitness Determinants during Energy-Limited Growth Arrest in <i>Pseudomonas aeruginosa</i>

Microbial growth arrest can be triggered by diverse factors, one of which is energy limitation due to scarcity of electron donors or acceptors. Genes that govern fitness during energy-limited growth arrest and the extent to which they overlap between different types of energy limitation are poorly defined. In this study, we exploited the fact that Pseudomonas aeruginosa can remain viable over several weeks when limited for organic carbon (pyruvate) as an electron donor or oxygen as an electron acceptor. ATP values were reduced under both types of limitation, yet more severely in the absence of oxygen. Using transposon-insertion sequencing (Tn-seq), we identified fitness determinants in these two energy-limited states. Multiple genes encoding general functions like transcriptional regulation and energy generation were required for fitness during carbon or oxygen limitation, yet many specific genes, and thus specific activities, differed in their relevance between these states. For instance, the global regulator RpoS was required during both types of energy limitation, while other global regulators such as DksA and LasR were required only during carbon or oxygen limitation, respectively. Similarly, certain ribosomal and tRNA modifications were specifically required during oxygen limitation. We validated fitness defects during energy limitation using independently generated mutants of genes detected in our screen. Mutants in distinct functional categories exhibited different fitness dynamics: regulatory genes generally manifested a phenotype early, whereas genes involved in cell wall metabolism were required later. Together, these results provide a new window into how P. aeruginosa survives growth arrest

Suppression of a cold-sensitive mutation in ribosomal protein S5 reveals a role for RimJ in ribosome biogenesis

A specific mutation of Escherichia coli ribosomal protein S5, in which glycine is changed to aspartate at position 28 [S5(G28D)], results in cold sensitivity and defects in ribosome biogenesis and translational fidelity. In an attempt to understand the roles of S5 in these essential cellular functions, we selected extragenic suppressors and identified rimJ as a high-copy suppressor of the cold-sensitive phenotype associated with the S5(G28D) mutation. Our studies indicate that RimJ overexpression suppresses the growth defects, anomalous ribosome profiles and mRNA misreading exhibited by the S5(G28D) mutant strain. Although previously characterized as the N-acetyltransferase of S5, our data indicate that RimJ, when devoid of acetyltransferase activity, can suppress S5(G28D) defects thus indicating that the suppression activity of RimJ is not dependent on its acetyltransferase activity. Additionally, RimJ appears to associate with pre-30S subunits indicating that it acts on the ribonucleoprotein particle. These findings suggest that RimJ has evolved dual functionality; it functions in r-protein acetylation and as a ribosome assembly factor in E. coli

Base methylations in the double-stranded RNA by a fused methyltransferase bearing unwinding activity

Modifications of rRNAs are clustered in functional regions of the ribosome. In Helix 74 of Escherichia coli 23S rRNA, guanosines at positions 2069 and 2445 are modified to 7-methylguanosine(m7G) and N2-methylguanosine(m2G), respectively. We searched for the gene responsible for m7G2069 formation, and identified rlmL, which encodes the methyltransferase for m2G2445, as responsible for the biogenesis of m7G2069. In vitro methylation of rRNA revealed that rlmL encodes a fused methyltransferase responsible for forming both m7G2069 and m2G2445. We renamed the gene rlmKL. The N-terminal RlmL activity for m2G2445 formation was significantly enhanced by the C-terminal RlmK. Moreover, RlmKL had an unwinding activity of Helix 74, facilitating cooperative methylations of m7G2069 and m2G2445 during biogenesis of 50S subunit. In fact, we observed that RlmKL was involved in the efficient assembly of 50S subunit in a mutant strain lacking an RNA helicase deaD

Binding of aminoglycoside antibiotics to helix 69 of 23S rRNA

Aminoglycosides antibiotics negate dissociation and recycling of the bacterial ribosome’s subunits by binding to Helix 69 (H69) of 23S rRNA. The differential binding of various aminoglycosides to the chemically synthesized terminal domains of the Escherichia coli and human H69 has been characterized using spectroscopy, calorimetry and NMR. The unmodified E. coli H69 hairpin exhibited a significantly higher affinity for neomycin B and tobramycin than for paromomycin (Kds = 0.3 ± 0.1, 0.2 ± 0.2 and 5.4 ± 1.1 µM, respectively). The binding of streptomycin was too weak to assess. In contrast to the E. coli H69, the human 28S rRNA H69 had a considerable decrease in affinity for the antibiotics, an important validation of the bacterial target. The three conserved pseudouridine modifications (Ψ1911, Ψ1915, Ψ1917) occurring in the loop of the E. coli H69 affected the dissociation constant, but not the stoichiometry for the binding of paromomycin (Kd = 2.6 ± 0.1 µM). G1906 and G1921, observed by NMR spectrometry, figured predominantly in the aminoglycoside binding to H69. The higher affinity of the E. coli H69 for neomycin B and tobramycin, as compared to paromomycin and streptomycin, indicates differences in the efficacy of the aminoglycosides